Carisma Therapeutics, Inc. (CARM)
OTCMKTS
· Delayed Price · Currency is USD
0.0438
+0.0023 (5.54%)
At close: Mar 9, 2026
Carisma Therapeutics Market Cap
Carisma Therapeutics has a market cap or net worth of $1.83 million as of March 9, 2026. Its market cap has decreased by -90.51% in one year.
Market Cap
1.83M
Enterprise Value
-182.19K
Revenue
52.63M
Ranking
n/a
PE Ratio
0.23
Stock Price
$0.04
Market Cap Chart
Since March 8, 2023, Carisma Therapeutics's market cap has decreased from 147.73M to 1.83M, a decrease of -98.76%. That is a compound annual growth rate of -76.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.74M | -3.49% |
| Dec 31, 2025 | 1.80M | -89.71% |
| Dec 31, 2024 | 17.48M | -85.21% |
| Dec 29, 2023 | 118.25M | -19.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agentix | 1.94M |
| inTerra Resources | 1.49M |
| ZyVersa Therapeutics | 2.10M |
| Vaccinex | 2.13M |
| Neon Bloom | 1.40M |
| Entia Biosciences | 1.37M |
| LakeShore Biopharma | 2.27M |
| VitaSpring Biomedical | 2.30M |